---
figid: PMC8747952__gr1_lrg
figtitle: An updated overview of recent advances, challenges, and clinical considerations
  of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- H1N1 subtype
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Staphylococcus aureus
pmcid: PMC8747952
filename: gr1_lrg.jpg
figlink: /pmc/articles/PMC8747952/figure/f0005/
number: F1
caption: The IL-6 pathway and the mechanisms of drugs inhibiting IL-6 pathway at different
  stages. Created by Esamaeilzdeh et al.
papertitle: An updated overview of recent advances, challenges, and clinical considerations
  of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).
reftext: Reza Elahi, et al. Int Immunopharmacol. 2022 Apr;105:108536-108536.
year: '2022'
doi: 10.1016/j.intimp.2022.108536
journal_title: International Immunopharmacology
journal_nlm_ta: Int Immunopharmacol
publisher_name: Published by Elsevier B.V.
keywords: Coronavirus disease-2019 | Interleukin-6 | Cytokine storm | Tocilizumab
  | Janus-kinase inhibitor
automl_pathway: 0.9617999
figid_alias: PMC8747952__F1
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8747952__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8747952__gr1_lrg.html
  '@type': Dataset
  description: The IL-6 pathway and the mechanisms of drugs inhibiting IL-6 pathway
    at different stages. Created by Esamaeilzdeh et al.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il6r
  - Adam17
  - Stat3
  - Nfkb1
  - Rela
  - Il6st
  - Il6
  - Socs3
  - IL6R
  - ADAM17
  - STAT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IL6ST
  - NM
  - LRPPRC
  - TRA-TGC7-1
  - IL6
  - SOCS3
  - Il6ra
  - Il11ra1
  - Lrpprc
---
